Cutaneous embolization of doxorubicin drug-eluting beads.
نویسندگان
چکیده
ridges and lesswithin the furrowsof thedermatoglyphs. Subsequent histopathologic analysis of those lesions demonstrated atypical melanocytes containing melanin granules within the crista profunda intermedia.6 Similarly, in their retrospective analysis of Japanese patients withmelanocytic lesions, Saida et al5 found the parallel ridge pattern more diagnostically accurateofmelanoma in situ than“irregular diffuse pigmentation.”5(p1235) Melanocyticnevi, subcornealhemorrhage, exogenouspigmentation, and lentiginosis and drug-induced hyperpigmentation candemonstrate a dermoscopic parallel ridge pattern.3 Benign dermoscopic attributes include a parallel furrow pattern,5 a lattice-like pattern,6 and/or the lack of disruption of the acrosyringia within the epidermal ridges.3 Our patient’s history suggested recent onset, an uncommon feature in ALM. Because we did not specifically inquire about exogenous pigment exposures, our initial evaluation failed to reveal information thatmay have allowed for earlier exclusion of ALM. Our case serves as a reminder to clinicians of the importanceof a thoroughhistory.Exogenous tissuedyeing should be considered in the differential diagnosis of acral pigmented lesions, particularly if the clinical history suggests the lesion is of recent onset.
منابع مشابه
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
Transarterial chemoembolization (TACE) is a widely used standard treatment for patients with hepatocellular carcinoma (HCC) who are not suitable candidates for curative treatments. The rationale for TACE is that intra-arterial chemotherapy using lipiodol and chemotherapeutic agents, followed by selective vascular embolization, results in a strong cytotoxic effect as well as ischemia (convention...
متن کاملEvaluation of ion exchange processes in drug-eluting embolization beads by use of an improved flow-through elution method.
An improved method for evaluating drug release behaviour of drug-eluting embolization beads (DEBs) was developed utilizing an open-loop flow-through system, in which the beads were packed into an occlusive mass within the system and extracted with a flowing elution medium over time. Glass beads were introduced into the beads mass in order to ensure laminar flow, reduce dead volume and improve r...
متن کاملTransarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared ...
متن کاملDrug-eluting beads loaded with antiangiogenic agents for chemoembolization: in vitro sunitinib loading and release and in vivo pharmacokinetics in an animal model.
PURPOSE The combination of embolic beads with a multitargeted tyrosine kinase inhibitor that inhibits tumor vessel growth is suggested as an alternative and improvement to the current standard doxorubicin-eluting beads for use in transarterial chemoembolization. This study demonstrates the in vitro loading and release kinetics of sunitinib using commercially available embolization microspheres ...
متن کاملHypoxia as a target for drug combination therapy of liver cancer
Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer deaths worldwide. The standard of care for intermediate HCC is transarterial chemoembolization, which combines tumour embolization with locoregional delivery of the chemotherapeutic doxorubicin. Embolization therapies induce hypoxia, leading to the escape and proliferation of hypoxia-adapted cancer cells. The transcriptio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- JAMA dermatology
دوره 150 10 شماره
صفحات -
تاریخ انتشار 2014